A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Irinotecan (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Gliosarcoma; Oligodendroglioma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 29 May 2015 Toxicity results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 14 May 2015 According to a Merrimack Pharmaceuticals media release, data from this trial will be presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 06 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.